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Abstract 
Summary 
Mechanical loading at high frequency affects bone. Whether this also applies to osteoporotic 
bone, combined or not with bisphosphonate therapy, was investigated in this animal study 
through imaging. An anabolic effect of high-frequency loading on osteoporotic bone, however 
non-synergistic with bisphosphonates, was found, thereby revealing its potential for treatment 
of osteoporosis. 
Introduction 
In an effort to elucidate the effect of high-frequency (HF) loading on bone and to optimize its 
potential for treatment osteoporosis, this study aimed to investigate the effect of HF loading 
via whole body vibration (WBV), alone or in association with bisphosphonate treatment 
(alendronate—ALN), on the micro-architecture of ovariectomy (OVX)-induced compromised 
bone. 
Methods 
Eighty-four female Wistar rats were ovariectomized (OVX) or sham-operated (shOVX). OVX 
animals were treated either with ALN (3 days/week at a dose of 2 mg/kg) or with saline 
solution. Each group (shOVX, OVX, ALN) was further divided into subgroups relative to the 
loading status (sham-WBV versus WBV) and the duration of experimental period (4 days 
versus 14 days). (Sham)WBV loading was applied for 10 min/day using 10 consecutive steps 
of HF loading (130, 135, 140, 145, 150, 130, 135, 140, 145, 150 Hz). Tibial bone structural 
responses to WBV and/or ALN treatment were analyzed using ex vivo micro-computed 
tomography. 
Results 
The animal’s hormonal status displayed a major impact on the trabecular and cortical bone 
structural parameters. Furthermore, mechanical treatment with HF WBV increased the 
cortical thickness and reduced the medullar area in OVX rats. However, OVX trabecular bone 
was not affected by HF stimuli. Finally, ALN prevented OVX-associated bone loss, but the 
association of ALN with WBV did not lead to a synergistic bone response in OVX bone. 
Conclusions 
HF WBV mechanical stimulation displayed an anabolic effect on osteoporotic cortical bone, 
confirming its therapeutic properties for enhancing compromised bone. Additionally, its 
association with bisphosphonates’ administration did not produce any additive effect on the 
bone micro-architecture in the present study. 
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Introduction 
Osteoporosis is an emerging medical and socioeconomic threat characterized by a systemic 
impairment of bone mass and strength, which increases the propensity of fragility fractures 
[1]. From a patient’s perspective, a fracture and the subsequent loss of mobility and autonomy 
often represent a major drop in quality of life. About 40 % of postmenopausal women are 
affected by osteoporosis and, with an aging population, this number is expected to steadily 
increase in the near future [2, 3]. Therefore, this disease has been an important public health 
issue because of the potentially devastating results and high prevalence in the population. 
Estrogen deficiency after menopause is one of the most common causes of osteoporosis in the 
population. In the estrogen-deficient state, the balance between bone resorption and bone 
formation shifts toward an increasing level of bone resorption, which results in the loss of 
bone mass and deterioration of the bone micro-architecture, since that adequate estrogen level 
is required to inhibit osteoclast maturation at cellular level and enhance the synthesis of 
cytokines that play roles in bone formation [4, 5]. Pharmaceutical treatment with 
antiresorptive drugs, anabolic agents, as well as selective estrogen modulators is commonly 
used for postmenopausal osteoporosis [6]. Although these drugs therapies are effective, most 
of them have some limitations and side effects that affect long-term administration and 
patient’s adherence [7]. Hence, there is a clear need for the development of novel agents that 
exhibit a low level of toxicity and side effects as new treatment options for osteoporosis [1]. 
In this context, the profound anabolic effects of mechanical signals on bone have prompted 
the development of diverse biomechanical approaches in the treatment of osteoporosis, for 
preventing bone loss, increasing bone quantity, and/or improving its quality [8]. In particular, 
the mechanical signals provided by high-frequency (HF) vibration loading have been shown 
to promote bone formation, increase bone strength, and even recover bone loss arising from 
disabling or osteoporotic conditions [9, 10]. However, the effects of HF vibration on bone 
tissue vary with vibration conditions, study design, timing of intervention, and at different 
anatomic sites [10, 11]. 
In an effort to further elucidate the single and combined effect of HF loading and 
bisphosphonate treatment on ovariectomy-induced osteoporotic bone and to explore their 
potential for the treatment of osteoporosis, the present study investigated the impact of the 
exposure of long bones to HF mechanical loading via whole body vibration (WBV) on the 
bone micro-architecture. An animal study, with rats characterized by either untreated or 
bisphosphonate-treated osteoporotic bone, was conducted, with a twofold hypothesis: (i) HF 
loading via WBV improves the trabecular and cortical micro-architecture of ovariectomy-
induced impaired bone and (ii) the concomitant application of mechanical treatment by means 
of HF WBV and pharmacological treatment by means of the antiresorptive drug alendronate 
results in a synergistic anabolic effect on the micro-architecture of osteoporotic bone. 
Materials and methods 
Animals and experimental design 
A total of 84 female Wistar rats at 12 weeks of age were used in the present study. Fifty-five 
animals underwent ovariectomy surgery [OVX], while the remaining 29 animals were 
subjected to sham-ovariectomy surgery [shOVX]. (Sham)-ovariectomy surgery was 
performed at Charles River Laboratories (Charles River, L’Arbresle, France). For the rats 
subjected to sham surgery, the bilateral ovaries were lifted up and returned to their original 
position, while for the ovariectomized rats, the ovaries were removed. Rats arrived 5 days 
post-(sham)OVX surgery, with a body weight ranging between 220 and 250 g. Pair-feeding 
regimen was initiated immediately in an attempt to control the body weight gain throughout 
the study. The average daily food consumption of the shOVX animals was determined, and 
the quantified amount was then provided to the other animals. Animals were weighed at the 
start and once a week during the study. The OVX group was divided into 2 groups, an 
untreated group [OVX] (n = 26) and a group treated with the antiresorptive bisphosphonate 
drug alendronate [ALN] (n = 29). Alendronate sodium trihydrate (A4978-100MG, Sigma-
Aldrich, Bornem, Belgium) was injected subcutaneously 3 days/week at a dose of 2 mg/kg 
body weight/dose, starting 5 days post-OVX surgery. Maintenance of bone tissue quantity and 
quality in OVX rats in response to such ALN dosage has been evidenced [12, 13]. Saline 
administration (0.9 % NaCl) was performed according to the same time schedule to the rats of 
the OVX and shOVX groups. Injections were administered till the day of euthanasia. Each 
group (shOVX versus OVX versus ALN) was further divided into subgroups relative to the 
loading condition (sham-WBV versus WBV) and to the duration of the experimental period 
(4 days versus 14 days), resulting in 6 experimental groups for each time point (Cf. Table S1 
Supplementary Material). The protocol of the animal experiment was approved by the ethical 
committee of KU Leuven (P050/2011), complied with ARRIVE guidelines for preclinical 
studies, and was performed according to the Belgian animal welfare regulations and 
guidelines. 
Vibration device and loading protocol 
HF mechanical loading was initiated 6 weeks post-(sham)ovariectomy. This time lapse was 
considered to be adequate for inducing significant bone changes in the rat long bones in 
response to ovariectomy [10]. The loading was applied by means of WBV via a custom-made 
vibration device, which was developed in collaboration with the Department of Mechanical 
Engineering, Division of Biomechanics KU Leuven (Cf. Fig. S1 Supplementary Material for 
detailed description of the vibration system) [14, 15]. As stated above, the animals were 
randomly divided into 2 groups according to the duration of experimental period. In one 
group (n = 43), the experiment lasted 4 days, while in the other group (n = 41), the experiment 
endured for 14 days. These time points were defined, based on the bone-anabolic potential of 
short-term application of HF loading in a bone-biomaterial healing context [14, 15] and on the 
accelerated turnover of bone tissue after estrogen withdrawal, hypothesizing that the short-run 
application of HF loading on bone of OVX rats may be discernable at tissue micro-level. Each 
group was subdivided into two groups, a sham-WBV-unloaded (shWBV) and a WBV-loaded 
group. The WBV loading was applied for 10 min/day according to a protocol that consisted of 
10 consecutive frequency steps (130, 135, 140, 145, 150, 130, 135, 140, 145, and 150 Hz), 
each of these applied for 1 min at an acceleration of 0.3g. Frequency signals higher than those 
used in previous studies (superior to 90 Hz) [10, 16–18] were applied in the attempt to obtain 
an osteogenic effect of HF WBV for both trabecular and cortical bone, as suggested by 
Rubinacci and co-workers [19]. In addition, such loading frequencies demonstrated an 
anabolic effect on bone healing during implant osseointegration [14, 15]. WBV was applied to 
the animals individually, taking into account the animal’s body weight. Intervals of 24 h 
between the loading sessions were respected. 
Specimen preparation and micro-X-ray computed tomography analysis 
After euthanasia of the animals by cervical displacement under isoflurane-induced anesthesia, 
the hindlimbs were excised and the surrounding soft tissues removed. The tibiae were 
retrieved and immediately fixated in 10 % CaCO3-buffered formalin solution (pH 7.4) at 4 °C 
for 48 h. The samples were further kept in the 70 % ethanol at 4 °C until the day of micro-X-
ray computed tomography (μCT) scanning. 
For assessment of the bone micro-architectural changes in response to the hormonal status, 
mechanical loading status, and duration of the experimental period, the proximal part of the 
tibiae was examined ex vivo using a desktop μCT system, commercially available as Skyscan 
1172 (Skyscan, Aartselaar, Belgium). During scanning, the tibia was placed in the 
polyethylene tube and immobilized inside the tubes by means of soft modeling clay. The bone 
samples were scanned along the midsagittal planes in the metaphyseal and mid-diaphyseal 
regions to obtain the μCT images. The scanning parameters were 6-μm pixel size, 50-kV X-
ray voltage, 200-μA electric current, and 0.5-mm Al filter. The scanning resulted in 
reconstructed 3D data sets with a voxel size of 6 μm, which were subsequently quantified 
using CTAn automated image analysis system (SkyScan, Aartselaar, Belgium). The registered 
gray-value images were segmented into binary images using a Gaussian filter and a fixed 
threshold (lower and the upper gray threshold values of 78 and 224, respectively) to extract 
the mineralized bone phase. Trabecular and cortical volumes of interest were defined, and the 
histomorphometric parameters were calculated according to the methodology described by 
Bouxsein and co-workers [20]. 
To determine the trabecular volume of interest (VOI) in the axial direction, the growth plate 
was determined as reference. The region of interest for the trabecular analysis started at the 
position of 1.5 mm downwards from the growth plate level and extended into the diaphysis 
over a distance of 3.3 mm (560 slices) (Fig. 1a). For each transverse slice, the VOI was 
delineated manually matching with the area occupied by trabecular bone (by freehand 
drawing—see Fig. 1b, c). The bone volume fraction (BV/TV), trabecular thickness (Tb.Th), 
trabecular separation (Tb.Sp), and trabecular number (Tb.N) were calculated 3D as 
measurements of trabecular bone mass and its distribution. The trabecular architecture was 
quantified by calculating the connectivity of the trabecular network (trabecular bone pattern 
formation, Tb.Pf) and the structure model index (SMI). Low Tb.Pf values reflect better 
connected trabecular lattices, whereas high Tb.Pf values indicate disconnected trabecular 
structures. The SMI values provide information regarding the trabecular shape, which is either 
rod- (SMI = 3) or plate-like (SMI = 0). 
 
Fig. 1  
Representative μCT images of tibia. a Region of interest (ROI) for trabecular bone analysis: 1.5 mm 
downwards from the growth plate level and extending into the diaphysis over a distance of 3.3 mm. b 
Manual delineating of the volume of interest (red-highlighted region) of the trabecular bone, by 
freehand drawing of a line parallel and close to the endocortical boundary, thereby separating the 
trabecular from cortical bone. c 3D view of the trabecular bone volume reconstructed from the 
selected ROIs. d ROI for cortical bone analysis: 4.2 mm distally from the growth plate level and 
extending toward the distal diaphysis for 1.5 mm. e Manual delineating of the volume of interest (VOI) 
of the cortical bone (gray-colored region), by freehand drawing starting at the endosteal side, 
continuing outside the cortical bone and ending with the closing of the loop. f 3D view of the cortical 
bone volume reconstructed from the selected ROI. More information on the method for ex vivo micro-
CT analysis of rat bone can be found at http://umanitoba.ca/faculties/medicine/units/cacs/sam/media/
MN003_Bone_microCT_analysis_rat.pdf  
To determine the cortical volume of interest in the axial direction, the growth plate was again 
used as reference. The region of interest of the cortical analysis was set with its closest edge at 
4.2 mm distally from the growth plate and extended toward the distal diaphysis for 1.5 mm 
(250 slices) (Fig. 1d). For each transverse slice, the VOI was delineated manually (freehand 
drawing of cortical bone area—see Fig. 1e, f). The periosteal perimeter (Ps.Pm), medullary 
area (Ma.Ar), endocortical perimeter (Ec.Pm), mean polar moment of inertia (MMI), and 
eccentricity (Ecc) were calculated 2D as measurements of cortical bone mass and its 
distribution. The porosity (Ct.Po) and cortical thickness (Ct.Th) were calculated 3D as 
measurements of cortical bone mass and its distribution. 
Statistical analysis 
Results were expressed as means and confidence intervals. The data were analyzed by three-
way factorial analysis of variance (ANOVA) and pairwise comparison tests in order to assess 
the effect of hormonal status, mechanical status, duration of the experimental period (i.e., the 
three independent variables), and their interactions on the trabecular and cortical bone micro-
architectural changes. Post hoc tests for pairwise comparisons were performed using the 
Tukey HSD test with Bonferroni correction. The statistical software package SPSS (SPSS ver. 
13.0, Chicago, IL, USA) was used. Differences were considered significant at p < 0.05. 
Results 
The body weight of OVX rats increased despite of the pair-feeding regime and 
HF loading 
The body weight recordings at the day of arrival of the animals (i.e., 5 days post-(sh)OVX 
surgery) revealed a slightly higher body weight for OVX animals compared to shOVX 
animals (235.6 versus 224.5 g, respectively). As a consequence of ovariectomy surgery, OVX 
animals indeed have the tendency to gain weight. However, 6 weeks later, it was observed 
that the established pair-feeding regimen was able to control the body weight gain in OVX 
animals (14.5 versus 14.5 g for OVX and shOVX animals, respectively). Surprisingly, at 
week 8 post-(sh)OVX surgery (corresponding to the end of the 14 days of WBV intervention), 
an almost twofold body weight gain of the OVX rats compared to that of shOVX animals was 
recorded (37.8 versus 14.05 g, respectively), despite the uninterrupted pair-feeding regime. 
Furthermore, independently of the allocated experimental group, ALN animals displayed a 
three- and twofold weight increase compared to the weight gain of shOVX and OVX, 
respectively. Finally, HF WBV application did not affect the rats’ body weight gain in all 
experimental groups (Cf. Fig. S2 Supplementary Material). 
ANOVA revealed significant effect of hormonal status, mechanical loading, 
duration of the experimental period, and their interactions on cortical and 
trabecular micro-structural parameters 
For the trabecular bone structural parameters, a three-way interaction between the hormonal 
status, the mechanical loading status, and the duration of the experimental period was found, 
implying that subsequent statistical analyses should make use of the full factorial model 
(Tables 1). Within this model, pairwise comparisons were performed with Bonferroni 
corrections up to a significance level of p < 0.00417 for the hormonal status and p < 0.0083 
for the mechanical status and for the duration of experimental period. The results are 
graphically presented in Fig. 2 and are discussed in detail below. For the cortical bone 
analysis, only two-way interactions between the independent variables were found (Table 2). 
Hence, a customized factorial model was used, and subsequent pairwise comparisons were 
performed with Bonferroni corrections at significance level of p < 0.0167 for the hormonal 
status and p < 0.0083 for the mechanical status and for the duration of experimental period. As 
two two-way interactions displayed significant results for the cortical bone 
(hormonal*mechanical and hormonal*duration), the results were displayed in separate 
figures. In Fig. 3, the impact of the hormonal status on the cortical bone parameters, relative 
to the loading condition, is displayed (data of the 4 days and 14 days experiment are pooled). 
In Fig. S3 of Supplementary Material appendix of this manuscript, the (to the authors’ opinion 
less relevant) results of the impact of the hormonal status relative to the duration of the 
experimental period on the cortical bone parameters are presented. 
Table 1  
ANOVA results of the effect of the independent variables (i.e., the hormonal status, the mechanical 
status, the duration of the experimental period, and their interactions) on the trabecular bone-
dependent variables (i.e., BV/TV, Tb.Th, Tb.Sp, Tb.N, Tb.Pf, SMI) 
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BV/TV p < 0.001* p = 0.608 p = 0.379 p = 0.095 p = 0.064 p = 0.360 p = 0.042* 
Tb.Th p = 0.003* p = 0.840 p < 0.001* p = 0.243 p < 0.001* p = 0.505 p = 1.000 
Tb.Sp p < 0.001* p = 0.054 p = 0.018* p = 0.030* p = 0.003* p = 0.602 p = 0.676 
Tb.N p < 0.001* p = 0.516 p = 0.089 p = 0.303 p = 0.482 p = 0.348 p = 0.087 
Tb.Pf p < 0.001* p = 0.939 p = 0.002* p = 0.629 p = 0.010* p = 0.557 p = 0.677 
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SMI p < 0.001* p = 0.796 p < 0.001* p = 0.715 p < 0.001* p = 0.185 p = 0.638 
BV/TV bone volume/tissue volume, Tb.Th trabecular thickness, Tb.Sp trabecular spacing, Tb.N 
trabecular number, Tb.Pf trabecular bone pattern formation, SMI structure model index; *p < 0.05 
 
Fig. 2  
Results of micro-CT analysis of the trabecular bone structural parameters according to the animal’s 
hormonal status, the mechanical loading status, and the duration of the experimental period, for bone 
volume/tissue volume (BV/TV, %); trabecular thickness (Tb.Th, μm); trabecular separation (Tb.Sp, 
μm); trabecular number (Tb.N, μm−1); trabecular bone pattern formation (Tb.Pf, μm−1); and structural 
model index (SMI). Dotted connection bars denote statistically significant results of the pairwise 
comparisons between the groups with differing hormonal status (shOVX versus OVX versus ALN). 
Double line connection bars display the statistically significant differences between groups with 
differing experimental duration (4 versus 14 days). Open versus filled symbols refer to 4 and 14 days 
data, respectively 
Table 2  
ANOVA results of the effect of the independent variables (i.e., the hormonal status, the mechanical 
status, the duration of the experimental period, and their interactions) on the cortical bone-dependent 
variables (i.e., Ct.Po, Ps.Pm, Ma.Ar, Ec.Pm, MMI, Ecc, Ct.Th) 
  Hormonal status 
Mechanical 
status Duration Hormonal*mechanical Hormonal*duration 
Ct.Po p = 0.002* p = 0.800  p = 0.000* p = 0.821  p = 0.000* 
  Hormonal status 
Mechanical 
status Duration Hormonal*mechanical Hormonal*duration 
Ps.Pm p = 0.000* p = 0.013* p = 0.047* p = 0.026* p = 0.772  
Ma.Ar p = 0.000* p = 0.001* p = 0.178  p = 0.057  p = 0.230  
Ec.Pm p = 0.000* p = 0.058  p = 0.000* p = 0.256  p = 0.000* 
MMI p = 0.000* p = 0.127  p = 0.904  p = 0.027* p = 0.496  
Ecc p = 0.115  p = 0.258  p = 0.375  p = 0.988  p = 0.943  
Ct.Th p = 0.000* p = 0.002* p = 0.000* p = 0.671  p = 0.030* 
Ct.Po cortical porosity, Ps.Pm periosteal perimeter, Ma.Ar medullary area, Ec.Pm endocortical 
perimeter, MMI mean polar moment of inertia, Ecc eccentricity, Ct.Th cortical thickness; *p < 0.05 
 
Fig. 3  
Results of micro-CT analysis of the cortical bone structural parameters according to the animal’s 
hormonal condition and the mechanical loading status, for cortical porosity (Ct.Po, %); periosteal 
perimeter (Ps.Pm, μm); endocortical perimeter (Ec.Pm, μm); cortical thickness (Ct.Th, μm); medullary 
area (Ma.Ar, μm2); mean polar moment of inertia (MMI, μm4); and eccentricity (Ecc). Owing to the lack 
of a 3-way interaction, the data of the 4 days and 14 days groups were pooled when analyzing the 
impact of the hormonal status on the cortical bone parameters, relative to the loading condition. Dotted 
connection bars denote statistically significant results of the pairwise comparisons between the groups 
with differing hormonal status (shOVX versus OVX versus ALN). Plain connection bars display the 
statistically significant differences between groups with differing mechanical status (shWBV versus 
WBV). The reader is referred to Fig. S1 of Supplementary Material for the results of the impact of the 
hormonal status relative to the duration of the experimental period on the cortical bone parameters 
Results of the trabecular bone structural parameters 
(i) 
Trabecular bone micro-architecture was affected mainly by hormonal status. 
The trabecular bone of OVX animals displayed a significantly decreased BV/TV and Tb.N, 
and a significant increased Tb.Sp, Tb.Pf, and SMI, compared to shOVX or ALN animals, 
evidencing the status of ovariectomy-induced osteopenia in the OVX group (Fig. 2). No 
statistically significant differences for all trabecular parameters were found between ALN and 
shOVX groups, thereby providing evidence for the efficacy of pharmacology treatment with 
alendronate in preventing ovariectomy-induced trabecular bone micro-architectural changes 
(Fig. 2). 
(ii) 
The applied HF loading did not affect the trabecular bone micro-architecture. 
Unlike the major impact of the hormonal status on the trabecular bone structural parameters, 
the mechanical intervention with HF stimuli did not affect the trabecular micro-architecture. 
(iii) 
Trabecular bone micro-architectural changes within a 10-day time span can be observed by 
μCT. 
Temporal alterations of all parameters, except of Tb.N, could be captured over a 10-day 
period (from 4 days till 14 days) (Fig. 2). In particular, the OVX group was prone to short-
term bone trabeculae evolutions with thickening of the bone trabeculae, increased spacing and 
a more rod-like shape, and more disconnected trabecular structures. 
  
Results of the cortical bone structural parameters 
(i) 
Also the cortical bone micro-architectural parameters are primarily affected by the hormonal 
status, in particular by ALN. 
The animals’ hormonal status exerted an effect on the cortical bone micro-architecture, 
independently of the duration of experimental period. OVX group in comparison to ALN 
showed a statistically significant decrease in Ps.Pm (OVX-WBV versus ALN-WBV), Ma.Ar 
(OVX-WBV versus ALN-WBV), MMI (OVX versus ALN), Ct.Th (OVX versus ALN), and 
an increase in Ec.Pm (OVX-shWBV versus ALN-shWBV) (Fig. 3). When compared to the 
shOVX group, OVX presented a thinner cortical thickness (OVX-shWBV versus shOVX-
shWBV) and an increased Ec.Pm (OVX versus shOVX) and Ma.Ar (OVX-shWBV versus 
shOVX-shWBV). In contrast to the trabecular bone results, comparisons between ALN and 
shOVX groups showed statistically significant differences for Ps.Pm, Ma.Ar, and MMI 
(Fig. 3). 
(ii) 
HF loading affected the cortical micro-architecture, though not synergistically with ALN. 
HF WBV mechanical treatment positively affected the shOVX cortical bone by decreasing 
Ma.Ar, and the OVX group by decreasing Ma.Ar accompanied by an increase in Ct.Th. 
Furthermore, a negative effect of WBV was observed in shOVX group, with a reduction in 
Ps.Pm. Finally, the mechanical loading did not result in any significant effect in the ALN 
group (Fig. 3). 
  
Discussion 
In the present study, it was evaluated how mechanical stimulation by means of HF loading of 
ovariectomized-induced osteoporotic bone, combined or not with pharmacological treatment 
(bisphosphonates), can affect the bone’s micro-structure. Hence, high-resolution micro-
computed tomography (μCT) was used to determine the changes in bone micro-architecture, 
since this method enables the quantitative assessment of the skeleton’s morphology thereby 
providing identification of patients with osteoporosis as well as evaluation of the impact of 
treatments [21]. It was hypothesized that (i) HF WBV loading improves the micro-
architecture of ovariectomy-induced impaired bone and that (ii) the concomitant application 
of HF WBV and bisphosphonates results in a synergistic anabolic effect on the bone micro-
architecture. The main findings of this study are represented schematically in Fig. 4, with the 
trabecular bone drawn as the inner circle with grids pattern and the cortical bone the gray halo 
surrounding the inner circle. The following findings can be highlighted: (i) HF loading via 
WBV did not affect trabecular bone but stimulated cortical bone, enhancing its thickness in 
OVX rats; (ii) although ALN was able to prevent ovariectomy-induced bone loss, its 
concomitant application with HF loading did not produce a synergistic bone response; and 
(iii) the hormonal status, characterized by the presence of estrogen in shOVX groups and the 
lack of this hormone in OVX group, displayed the major impact on the trabecular and cortical 
bone micro-structural parameters evaluated. 
 
Fig. 4  
Schematically, representation of the main results of the bone morphometric parameters changes in 
response to mechanical and/or pharmaceutical treatment. The results for the parameters SMI, MMI, 
Ec.Pm, and Ecc are not included in the figure, as the schematic presentation of these parameters is 
not possible. Trabecular bone is represented by the inner circle with grids pattern and cortical bone by 
the gray halo surrounding the inner circle. a Impact of mechanical status on bone micro-architecture. 
HF loading via WBV did not affect trabecular bone (trabecular bone not shown) but affected cortical 
bone. The resulting effect of HF WBV on the cortical bone is represented by the gray halo, while the 
dotted circumferences represent the initial condition (i.e., prior to mechanical stimulation; shWBV). 
After application of HF WBV for an extended period of time, the shOVX group showed a reduction in 
Ps.Pm and Ma.Ar. The OVX group presented a decrease in Ma.Ar accompanied by an increase in 
Ct.Th. No changes in response to HF WBV were observed in the cortical bone structural parameters 
of the ALN group. b Impact of hormonal status on bone micro-architecture. In trabecular bone, OVX 
animals displayed a significant decreased in BV/TV and Tb.N, and a significant increased Tb.Sp and 
Tb.Pf when compared to shOVX and ALN animals. Furthermore, no statistically significant differences 
for all trabecular parameters were noted between ALN and shOVX groups. In cortical bone, OVX in 
comparison to shOVX presented an increase in Ma.Ar and Ec.Pm and consequently a thinner cortical 
thickness. Comparisons between OVX and ALN group showed an increase in Ps.Pm and in Ct.Th in 
ALN group. In contrast to the trabecular bone results, comparisons between ALN and shOVX groups 
showed statistically significant differences, in particular an increased Ps.Pm and Ma.Ar. The plain gray 
halo represents the bone structural changes resulting from the hormonal status; the dotted line 
circumferences the reference bone condition. A bold outline of the cortical bone indicates an increased 
periosteal perimeter 
Indeed, estrogen is the major hormonal regulator of bone metabolism in women [22]. The 
ovariectomized rat model was used to simulate postmenopausal osteoporosis [23], and the 
resulting withdrawal of estrogen after ovariectomy surgery induces a rapid increase in bone 
turnover associated with a substantial bone loss [22]. As a consequence of this unbalanced 
process, a compromised bone condition was established in the OVX group, as quantified in 
the present study by the reduction of BV/TV, Tb.N, Tb.Th, and Ct.Th and by an increase in 
SMI, Tb.Pf, Tb.Sp, Ma.Ar, and Ec.Pm as compared to shOVX group. Similar changes in bone 
structural parameters after ovariectomy have been reported in other reports [16, 17, 24, 25]. 
Nonetheless, the pharmacology treatment of OVX rats with the bisphosphonate drug 
alendronate was able to prevent ovariectomy-induced bone loss. Our results consistently 
indicated the preservation of the trabecular and the cortical bone in response to ALN 
administration in OVX rats, corroborating with the findings from clinical studies reporting a 
favorable effect of ALN treatment on the bone in postmenopausal women [26]. ALN is an 
antiresorptive agent preventing osteoporosis-related deterioration of bone by decreasing the 
bone resorption [27]. More specifically, ALN is a nitrogen-containing bisphosphonate, which 
inhibits the enzyme farnesyl pyrophosphate (FPP) synthase, thereby disrupting the production 
of isoprenoid lipids in the mevalonate pathway, preventing the prenylation of small GTPase 
proteins necessary for osteoclast function and causing accumulation of a toxic, isoprenoid-
containing metabolite that disrupts osteoclast function and survival [28]. As a result of the 
bone resorption suppression by ALN administration, trabecular bone structural parameters 
were maintained in ovariectomized rats, with similar values as those of the shOVX rats 
(normal bone). In the cortical bone, besides preserving the bone structural parameters affected 
by ovariectomy, ALN bone compared to shOVX bone displayed decreased (though not 
significantly) cortical porosity (Ct.Po) and significantly increased periosteal perimeter 
(Ps.Pm), mean polar of inertia (MMI), and medullar area (Ma.Ar). In agreement with these 
results, previous studies have reported that bisphosphonates reduce remodeling and therefore 
decrease cortical porosity by increasing the uniformity of mineralization [29]. Also, periosteal 
expansion occurs in response to ALN treatment, thereby increasing the medullary area and 
cortical thickness compared to control bone [30]. Consequently, these cortical bone structural 
changes might contribute for improving the bone biomechanical behavior, which could reduce 
the incidence of bone fractures in patients with osteoporosis. 
Unlike pharmacological treatment with ALN, the mechanical treatment with HF via WBV did 
not improve the trabecular bone structural parameters in OVX group. The lack of success of 
the HF loading treatment on the trabecular bone can potentially be associated to its short-term 
exposure as well as to the withdrawal of estrogen after ovariectomy in this group. Estrogen 
appears to possess a permissive role on the osteogenic effects of mechanical loading on bone 
through the involvement of α-form estrogen receptor (ER-α) in the mechanosensing pathway 
of bone cells [31–33]. As ER-α expression in osteoblasts and osteocytes depends on estrogen 
concentration [34], a failure to maintain bone mass and strength after the menopause might be 
due to a reduction in the activity or number of ER-α in bone cells, thereby limiting their 
anabolic response to mechanical loading and allowing bone loss comparable to that associated 
with disuse [31]. In contrast to these trabecular bone findings, an osteogenic effect of HF 
mechanical loading was observed in the cortical bone of OVX group, resulting in a significant 
smaller medullar area and thicker cortical thickness. In agreement with these results, 
Rubinacci and co-workers reported that the osteogenic potential of WBV is limited to the 
bone cortex in OVX rats [19]. Such results might be a consequence of the stimulation of the 
periosteal bone by mechanical loading after the menopause [30]. Increased periosteal 
apposition causes the cortical shell to move further from the long axis of bone, and the larger 
bone size improves their resistance to fractures [35]. This implies that it is possible to lose 
total bone mass but still have equally or elevated mechanically competent bones since that 
increases in the cortical thickness will increase the bone bending moment and consequently its 
strength, enhancing its overall mechanical competence [35]. 
Cortical bone remodeling is a direct consequence of the surface-specific effects of estrogen on 
bone in response to loading. However, it is important to note that besides ER-α, estrogen has 
also a β-form of receptor involved in the mechanotransduction. These receptors have 
opposing effects on bone formation, and their expression differs on each bone surface as well 
as during the different stages of osteoblast differentiation [36]. Signaling through ER-α 
enhances mechanically induced bone formation [31, 32] while signaling through ER-β 
suppresses mechanically induced periosteal bone formation [36, 37]. Consequently, in a state 
of estrogen deficiency, as in the menopause, the lack of inhibitory ER-β signaling might 
activate a compensatory mechanism in order to maintain bone mechanical resistance despite 
the loss of bone at the endocortical surface [19, 36]. In contrast to the OVX group where a 
suppression of ER-β signaling is suggested as potential mechanism of action, activation of 
this receptor by the estrogen presence might have occurred in shOVX group. This fact can 
explain why the mechanical loading treatment of shOVX induced a negative response at the 
cortical region, with a reduction in the periosteal perimeter. In line with this assumption, 
Saxon and co-workers demonstrated that the treatment with estrogen, even at low dose, 
suppressed periosteal bone formation occurring after mechanical loading [38]. The authors 
reported that the osteogenic loading response at the periosteal surface was reduced through 
estrogen treatment by 48 % after 1 week of mechanical loading, and this decrease in bone 
formation caused reductions in the loading-induced gains in cortical area, moment of inertia, 
and bone mineral content after 5 weeks of loading [38]. 
Despite the cortical bone-anabolic response in OVX animals to the mechanical HF WBV 
intervention as well as to the pharmacological treatment with ALN, the concomitant 
application of both treatments did not produce a synergistic bone response. The values of the 
bone micro-structural parameters for ALN-shWBV and ALN-WBV groups were in the same 
range, suggesting the lack of effect of WBV in the ALN group. Previous studies showed 
similar results and attested that WBV exercise and ALN did not have any additive effects on 
the lumbar spine bone mineral density [39] and on the urinary and serum bone formation 
levels in postmenopausal women [40]. Likewise, Lespessailles and co-workers reported that 
zoledronic acid and running exercises did not produce any additive effects on bone mass and 
strength [41], whereas Fuchs et al. showed that combination of running exercise and ALN 
was more beneficial in preventing declines in bone mass and strength than either intervention 
alone [42]. Compared with the study of Fuchs et al., a higher dose of ALN was used in the 
current study (0.015 mg/kg body weight at 2 days/week versus 2 mg/kg body weight at 
3 days/week). Therefore, the effect of mechanical loading on the bone micro-architecture 
could possibly be masked by the strong influence of alendronate on bone in the present study. 
Furthermore, in the referred study, a different kind of mechanical stimulation was applied, in 
which the rats were exercised on a motorized treadmill 5 days/week at 5 % incline for 
14 weeks. Finally, HF WBV loading was applied in the present study for only a limited period 
of time. Further studies are therefore necessary and ongoing, for evaluating the interaction of 
different dosages of alendronate with WBV, applied for varying time periods, on the bone 
micro-architecture and strength. 
Similarly to the pharmacologic treatment with ALN, no association could be found between 
the mechanical status and the duration of the experimental period. Nonetheless, there was a 
significant association between the hormonal status and the duration of the experimental 
period, indicating that some bone parameter changes could be captured within a 10-day 
period. In particular, the trabecular bone (Tb.Th, Tb.Sp, Tb. Pf, SMI) of the OVX rat seemed 
to be prone to short-term changes. Such evolutions have been reported by others though with 
observation intervals of 4 weeks or more [43, 44]. Noteworthy mentioning is that the 
increased body weight and resulting increased skeletal loading of the OVX animals was 
unable to remediate these bone deterioration changes. To avoid this body weight gain in OVX 
group, pair-feeding was established immediately after the rats’ arrival but was apparently 
unable to control the weight gain during the entire experimental period. The effect of OVX on 
subsequent gain in fat tissue has been extensively examined and has been associated with 
more adipogenesis than osteogenesis [45]. 
A limitation of the present experimental set-up is the short period of mechanical HF 
intervention (4 or 14 days). It could be that longer periods of vibration therapy would have 
induced more pronounced effects on bone mass. However, in other studies using OVX 
rodents and applying WBV therapy for 8 weeks or more, a substantial effect of this 
mechanical loading scheme on bone was neither found [17, 25]. Other factors like the study 
design and the loading frequency could play a more prominent role in the response of the 
bone tissue to WBV. Furthermore, the biomechanical properties of the bone were not 
evaluated in this study. As osteoporosis is characterized by decreased bone volume, micro-
architectural deterioration, decreased bone strength, and increased fracture risk, future studies 
evaluating how the changes in bone micro-structure in response to different treatments 
(mechanical or pharmacological) contribute to bone biomechanical properties are necessary. 
Finally, whether the cortical bone response to HF loading was due to increased bone 
formation or decreased bone resorption could not be answered as no dynamic bone 
histomorphometry nor the kinetic evaluation of the bone response (via the inclusion of more 
time points) was applied. 
Within the limitations of this study, it can be concluded that HF WBV mechanical stimulation 
can have an anabolic effect on the cortical bone part of ovariectomy-induced osteoporotic 
rats. However, the osteoporotic trabecular bone seemed to be less prone to HF WBV loading 
influences. Additionally, the association of this mechanical loading treatment with 
alendronate administration did not produce any additive effect on the bone micro-architectural 
response, when compared with ALN therapy alone, suggesting that the selected ALN dosage 
might have masked the effect of HF WBV on the bone. Hence, the study hypotheses could 
only partially be sustained. 
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